Sessions

For more than a decade, Jordan has built a wide and highly effective network. Now, it runs itself and incoming opportunities are virtually automated. He will teach you the same skills, systems and habits that he teaches to high-performers in military special operations, the intelligence services, government & Silicon Valley so that you can leverage what most people dread into one of your strongest competitive advantages.

With the mid-term congressional elections, as well as many state/local contests happening just weeks after the conference, join us for this timely general session where one of the country’s top political analysts previews what may happen on election day.

The COVID-19 pandemic helped accelerate the adoption of Digital Health Technologies, including telemedicine, wearable health devices, apps and the use of artificial intelligence to guide decision-making. The growing acceptance of digital health technologies will surely foster further development of these innovative applications. This session will feature a variety of examples demonstrating how DHT is being used by providers, patients and payers to improve access and outcomes for members of self-insured health benefit plans.

As potentially curative therapies come to market, risk bearing entities struggle with how to plan for and pay for therapies with record breaking price tags. SIIA has dedicated many sessions at conferences and held webinars to learn best practices for preparing for the wave of approvals expected over the next decade. Other professional associations focus on the impact for clinicians and benefits for patients. The remaining stakeholder is the organization bringing these emerging therapies forward – the manufacturer. Please join us for a panel discussion focused on the perspective of the manufacturer. We will discuss the process of FDA approval and the hurdles related to clinical trials, the technology and where it may go over the next decade and finally the cost to develop these therapies and the manufacturers view on value, value-based payments and warranties.

The business world seems to get more complicated everyday, resulting in increased financial risks. Given that the commercial insurance market often cannot keep up with these emerging risks, conventional wisdom takes shape that such risks are “uninsurable.” But that’s not always the case. In fact, captive insurance strategies have become increasingly sophisticated in recent years to allow businesses to account for and manage such risks. This session will highlight some real-world examples of how captive insurance is solving “uninsurable” risk challenges today and preview potential future financial risk management made possible by captives.

This session has been organized specifically for younger (under 40) professionals to talk about career advancement opportunities, challenges, and strategies generally, as well as those specific to the self-insurance industry. Share with and learn from your peers in this exclusive setting. The next generation of industry leaders will be represented in this room so you don’t want to miss out.

With more U.S. employers moving into self-insurance to contain employee benefit costs, the medical stop-loss market has grown by more than 40% over the last four years, reaching $25.2 billion in 2020, according to A.M. Best & Co. But the number and size of claims paid by stop-loss insurers are also surging thanks to specialty pharmacy costs, including cell and gene therapy, which now represents 35% to 40% of stop-loss claim costs. This session will address these and other emerging trends in the Employer Stop-Loss Market, including the impact of COVID, mounting behavioral health and substance abuse claims, and the evolving use of captives to fund ESL.

This unique interactive session will have direct discussions among the audience, including captive industry participants and state regulators, on top of mind regulatory and legislative issues in the captive insurance space. Bring up hot topics, learn what’s going on among regulators, and what may be coming in the future.

We are experiencing the greatest workforce disruption in generations, and the pace is likely to intensify. Join SIIA’s 2022 Chairwoman as she moderates a live and unscripted discussion forum where we will address today’s most pressing workforce challenges. Expected topics include “sitting is the new smoking,” competing in the war for knowledgeable worker talent, and building a corporate culture that can withstand how unevenly this disruption plays out across your organization.

After hearing from the cell & gene therapy manufacturers in the morning, please join us for an afternoon open discussion on how the self-insurance industry can best prepare for the amazing but highly expensive medical advancements that are coming fast.

Surprise medical billing, health care price transparency and drug pricing have all been top of mind policy issues on the federal and state level. SIIA’s government relations team will provide the latest policy updates and details on what self-insurance industry participants need to know to navigate through the new requirements, in addition to what to expect over the coming year on the healthcare policy and regulatory front.

Perhaps the biggest point of confusion within the self-insurance marketplace is what to believe with regard to PBM business practices and compensation arrangements. So we had an idea…gather together several of the leading PBMs in one room and ask them candid questions that are top of mind of SIIA members who have an interest in controlling pharmacy spends.

While benefits brokers and third-party administrators have a symbiotic relationship, they are not really “partners” in the true sense of the word. The role of the broker is to advocate for their clients, making sure they are getting the most efficient and cost-effective services to support their self-insured benefit plans. While the principal role of the TPA is to administer claims, some also provide access to stop-loss coverage, provider networks and other ancillary services, often on a bundled basis. But conflicts can arise if a broker seeks a la carte arrangements with service providers that do not already have contracts with the TPA. Other clashes might occur over transparency or how TPAs are paid. This session will explore the myriad issues that brokers and TPAs face when dealing with each other, and how they can be resolved amicably--in the best interests of their self-insured employer clients.

So what are the big trends and developments happening in the captive insurance market segment right now? SIIA will be collecting data and perspectives from a large population of those involved with a variety of captive insurance arrangements as part of its 2022 industry study. This session will unveil the results with related commentary from a panel of industry leaders.

By the time of the conference, it is expected that many surprise billing claims will have been resolved via arbitration as prescribed by the No Surprises Act (NSA). We’ll take this opportunity to talk about how the arbitration process is actually working, with a particular emphasis on the self-insured payer perspective. So come share your stories and listen to the experience of others who have had real world involvement with the NSA arbitration process.

A panel of leading reinsurance executives will provide perspectives on topics to include market capacity, cell & gene therapy, COVID impacts on results, syndication arrangements, mergers & acquisitions, and how reinsurers view a variety of risk transfer opportunities.

Join other attendees to broach the hottest industry topics and questions, from risk strategy and mitigation, how to tackle emerging risk, and the evolving dynamic of working with carriers in the captive space. The audience will also be asked their own takes on key results from SIIA’s 2022 Captive Industry Survey.

Artificial Intelligence and Machine Learning are quickly replacing the use of surveys and questionnaires by medical stop-loss underwriters to determine premiums, attachment points, lasers, and other coverage terms. By using AL and ML to track the pattern of past claims, underwriters can more accurately project claims costs and identify potentially high-cost claimants early. This session will provide a high-level overview of how AI and ML is improving medical stop-loss underwriting.

Are you responsible for organizational growth made possible by effective sales strategies? Trying to understand how the acceleration of change, challenges of staffing, and other industry developments is shifting the mind of the buyer in the self-insurance value chain? If this resonates with you, please join us for a forward-focused open conversation where everyone will be encouraged to share their experiences and strategies on how to work most effectively to support the self-insurance industry buyers while achieving your corporate growth objectives.